| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B-
Develop Normally, But Have Selective Defects in Proliferation and Function1
,
,¶
Departments of
*
Microbiology and Immunology and
Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232;
Howard Hughes Medical Institute, Chevy Chase, MD 20815;
Vanderbilt-Ingram Cancer Center, Nashville, TN 37232; and
¶ Transplantation and Immunobiology Section, Division of Allergy, Immunology, and Infectious Disease, National Institutes of Health, Bethesda, MD 20892
NF-
B has been implicated in the development, activation, and
function of B and T lymphocytes. We have evaluated the in vivo effects
of deletion of IB-
, a major inhibitor of NF-B, on lymphocyte
development, proliferation, and function. To elucidate the long term
role of IB- in lymphocytes, fetal liver cells of 14.5-day-old
IB--/- or wild-type embryos were transplanted into
irradiated recombinase-activating gene-2-deficient mice. Within 4 wk,
the IB--/- fetal liver cells reconstitute mature B
and T cell populations in the recipients comparable to those produced
by wild-type fetal liver cells. However, the proliferative responses of
IB--/- B cells are enhanced, whereas those of
IB--/- T cells are reduced. The levels of IgG1,
IgG2a, IgA, and IgE produced by IB--/- B cells are
elevated relative to those produced by IB-+/+ or
IB-+/-. Moreover, the specific immune
responses to OVA and the generation of germinal centers are impaired in
recipients of IB--/- fetal liver cells. These
results indicate that IB- plays a vital role in signal
transduction pathways regulating lymphocyte proliferation and also in
the production of specific Ig isotypes.
This article has been cited by other articles:
|
|
 |
|
  W. Han, M. Joo, M. B. Everhart, J. W. Christman, F. E. Yull, and T. S. Blackwell Myeloid cells control termination of lung inflammation through the NF-{kappa}B pathway Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L320 - L327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Jin, Y. Lho, L. Connelly, Y. Wang, X. Yu, L. Saint Jean, T. C. Case, K. Ellwood-Yen, C. L. Sawyers, N. A. Bhowmick, et al. The Nuclear Factor-{kappa}B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth Cancer Res., August 15, 2008; 68(16): 6762 - 6769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Groesdonk, F. Wagner, B. Hoffarth, M. Georgieff, and U. Senftleben Enhancement of NF-{kappa}B Activation in Lymphocytes Prevents T Cell Apoptosis and Improves Survival in Murine Sepsis J. Immunol., December 15, 2007; 179(12): 8083 - 8089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, X. Wang, R. Y.-L. Yu, B. B. Ding, J. J. Yu, X.-M. Dai, A. Naganuma, E. R. Stanley, and B. H. Ye BCL-6 Negatively Regulates Expression of the NF-{kappa}B1 p105/p50 Subunit J. Immunol., January 1, 2005; 174(1): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Goudeau, F. Huetz, S. Samson, J. P. Di Santo, A. Cumano, A. Beg, A. Israel, and S. Memet I{kappa}B{alpha}/I{kappa}B{epsilon} deficiency reveals that a critical NF-{kappa}B dosage is required for lymphocyte survival PNAS, December 23, 2003; 100(26): 15800 - 15805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Brantley, C.-L. Chen, R. S. Muraoka, P. B. Bushdid, J. L. Bradberry, F. Kittrell, D. Medina, L. M. Matrisian, L. D. Kerr, and F. E. Yull Nuclear Factor-{kappa}B (NF-{kappa}B) Regulates Proliferation and Branching in Mouse Mammary Epithelium Mol. Biol. Cell, May 1, 2001; 12(5): 1445 - 1455. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
